Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed lebrikizumab study is displayed, including its study design, eligibility criteria, outcomes, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-07T16:37:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T16:45:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:24:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T21:53:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, indicating the requested study record could not be loaded. This replaces the previous study details and navigation with a standard error screen.
    Difference
    17%
    Check dated 2026-09-19T19:15:19.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.